304 related articles for article (PubMed ID: 22796156)
1. Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease.
Xie L; Yui J; Hatori A; Yamasaki T; Kumata K; Wakizaka H; Yoshida Y; Fujinaga M; Kawamura K; Zhang MR
J Hepatol; 2012 Nov; 57(5):1076-82. PubMed ID: 22796156
[TBL] [Abstract][Full Text] [Related]
2. Utility of Translocator Protein (18 kDa) as a Molecular Imaging Biomarker to Monitor the Progression of Liver Fibrosis.
Hatori A; Yui J; Xie L; Kumata K; Yamasaki T; Fujinaga M; Wakizaka H; Ogawa M; Nengaki N; Kawamura K; Wang F; Zhang MR
Sci Rep; 2015 Nov; 5():17327. PubMed ID: 26612465
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa).
Hatori A; Yui J; Yamasaki T; Xie L; Kumata K; Fujinaga M; Yoshida Y; Ogawa M; Nengaki N; Kawamura K; Fukumura T; Zhang MR
PLoS One; 2012; 7(9):e45065. PubMed ID: 22984611
[TBL] [Abstract][Full Text] [Related]
4. [
Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
[TBL] [Abstract][Full Text] [Related]
5. 18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain.
Yui J; Maeda J; Kumata K; Kawamura K; Yanamoto K; Hatori A; Yamasaki T; Nengaki N; Higuchi M; Zhang MR
J Nucl Med; 2010 Aug; 51(8):1301-9. PubMed ID: 20660373
[TBL] [Abstract][Full Text] [Related]
6. Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa).
Hatori A; Yui J; Xie L; Yamasaki T; Kumata K; Fujinaga M; Wakizaka H; Ogawa M; Nengaki N; Kawamura K; Zhang MR
PLoS One; 2014; 9(1):e86625. PubMed ID: 24466178
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S
Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice.
Liu B; Le KX; Park MA; Wang S; Belanger AP; Dubey S; Frost JL; Holton P; Reiser V; Jones PA; Trigg W; Di Carli MF; Lemere CA
J Neurosci; 2015 Nov; 35(47):15716-30. PubMed ID: 26609163
[TBL] [Abstract][Full Text] [Related]
9.
Chung SJ; Yoon HJ; Youn H; Kim MJ; Lee YS; Jeong JM; Chung JK; Kang KW; Xie L; Zhang MR; Cheon GJ
J Nucl Med; 2018 May; 59(5):839-845. PubMed ID: 29326355
[TBL] [Abstract][Full Text] [Related]
10. In vivo imaging and quantitative analysis of TSPO in rat peripheral tissues using small-animal PET with [18F]FEDAC.
Yanamoto K; Kumata K; Fujinaga M; Nengaki N; Takei M; Wakizaka H; Hosoi R; Momosaki S; Yamasaki T; Yui J; Kawamura K; Hatori A; Inoue O; Zhang MR
Nucl Med Biol; 2010 Oct; 37(7):853-60. PubMed ID: 20870161
[TBL] [Abstract][Full Text] [Related]
11. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
Tomita K; Teratani T; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Nishiyama K; Mataki N; Irie R; Minamino T; Okada Y; Kurihara C; Ebinuma H; Saito H; Shimizu I; Yoshida Y; Hokari R; Sugiyama K; Hatsuse K; Yamamoto J; Kanai T; Miura S; Hibi T
J Hepatol; 2012 Oct; 57(4):837-43. PubMed ID: 22641095
[TBL] [Abstract][Full Text] [Related]
12. PET imaging of translocator protein (18 kDa) in a mouse model of Alzheimer's disease using N-(2,5-dimethoxybenzyl)-2-18F-fluoro-N-(2-phenoxyphenyl)acetamide.
James ML; Belichenko NP; Nguyen TV; Andrews LE; Ding Z; Liu H; Bodapati D; Arksey N; Shen B; Cheng Z; Wyss-Coray T; Gambhir SS; Longo FM; Chin FT
J Nucl Med; 2015 Feb; 56(2):311-6. PubMed ID: 25613536
[TBL] [Abstract][Full Text] [Related]
13. A first-in-man study of [
Tamura K; Nishii R; Tani K; Hashimoto H; Kawamura K; Zhang MR; Maeda T; Yamazaki K; Higashi T; Jinzaki M
Ann Nucl Med; 2024 Apr; 38(4):264-271. PubMed ID: 38285284
[TBL] [Abstract][Full Text] [Related]
14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
15. Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats.
Sridharan S; Lepelletier FX; Trigg W; Banister S; Reekie T; Kassiou M; Gerhard A; Hinz R; Boutin H
Mol Imaging Biol; 2017 Feb; 19(1):77-89. PubMed ID: 27481358
[TBL] [Abstract][Full Text] [Related]
16. S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.
Liu X; Wang Y; Ming Y; Song Y; Zhang J; Chen X; Zeng M; Mao Y
PLoS One; 2015; 10(5):e0127352. PubMed ID: 25993652
[TBL] [Abstract][Full Text] [Related]
17. [18F]FEBMP: Positron Emission Tomography Imaging of TSPO in a Model of Neuroinflammation in Rats, and in vitro Autoradiograms of the Human Brain.
Tiwari AK; Ji B; Yui J; Fujinaga M; Yamasaki T; Xie L; Luo R; Shimoda Y; Kumata K; Zhang Y; Hatori A; Maeda J; Higuchi M; Wang F; Zhang MR
Theranostics; 2015; 5(9):961-9. PubMed ID: 26155312
[TBL] [Abstract][Full Text] [Related]
18. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [
Deussing M; Blume T; Vomacka L; Mahler C; Focke C; Todica A; Unterrainer M; Albert NL; Lindner S; von Ungern-Sternberg B; Baumann K; Zwergal A; Bartenstein P; Herms J; Rominger A; Brendel M
Neuroimage; 2018 Jan; 165():83-91. PubMed ID: 28988133
[TBL] [Abstract][Full Text] [Related]
19. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease.
Asanuma T; Ono M; Kubota K; Hirose A; Hayashi Y; Saibara T; Inanami O; Ogawa Y; Enzan H; Onishi S; Kuwabara M; Oben JA
Gut; 2010 Feb; 59(2):258-66. PubMed ID: 19919948
[TBL] [Abstract][Full Text] [Related]
20. Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model.
Tantawy MN; Charles Manning H; Peterson TE; Colvin DC; Gore JC; Lu W; Chen Z; Chad Quarles C
Mol Imaging Biol; 2018 Apr; 20(2):200-204. PubMed ID: 28822038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
